Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Cardiology

The Standard of Care and Treatment Options

At a Glance

Rheumatic heart disease is treated first with regular antibiotics to prevent repeat rheumatic fever. Medicines can control fluid buildup and irregular rhythms, while severe valve damage may require a balloon procedure, valve repair, or replacement chosen according to the valve’s condition.

The standard of care for rheumatic heart disease (RHD) is a multi-step approach that starts with preventing further damage and moves into complex medical and surgical management as the disease progresses [1]. The goal is to keep your heart functioning well while avoiding the serious complications of valve failure.

The Foundation: Secondary Prophylaxis

The most critical part of treating early or “silent” RHD is secondary prophylaxis—regular doses of antibiotics to prevent new strep infections and recurrent rheumatic fever [1][2].

  • The Gold Standard: An injection of benzathine penicillin G every 3 to 4 weeks is the most effective treatment [1]. Research shows these injections are much better than oral pills at preventing the return of rheumatic fever [3].
  • Duration: Depending on guidelines and your history (such as whether you had carditis), you may need these injections for 10 years or until age 21 [4]. If you have severe heart damage, your doctor may recommend injections for a much longer period, sometimes to age 40 or for life [5].
  • Alternatives: Oral antibiotics (like penicillin V or erythromycin) may be used if injections are not possible or if you have a confirmed penicillin allergy, guided by your doctor [6].
  • Safety: Serious allergic reactions to injections are rare but possible. Seek emergency help for trouble breathing or facial swelling immediately after an injection.

Medical Management for Complications

As heart valves become more damaged, the heart may begin to struggle. Doctors use specific medications to manage these symptoms:

  • Heart Failure: If your heart cannot pump enough blood, you may experience “congestion” (fluid buildup). This is often treated with diuretics (“water pills”) to remove extra fluid. Depending on your valve lesion and heart function, ACE inhibitors or beta-blockers may also be used [7][8].
  • Atrial Fibrillation (AFib): This is a common irregular heartbeat in RHD patients [9]. For RHD patients with atrial fibrillation and moderate-to-severe rheumatic mitral stenosis, or a mechanical valve, warfarin (a vitamin-K antagonist) is the standard and most effective choice [9][10]. Never start, stop, or switch anticoagulants without your treating team’s guidance.

Choosing the Right Procedure

If your valve damage becomes severe, medication alone is not enough. The choice of procedure depends on how your valve looks on an ultrasound [11][12].

Procedure When it is Used Benefits & Risks
PBMV (Balloon Procedure) Considered for severe mitral stenosis when the valve is still flexible and lacks major clots or leaks [13]. Benefit: No open-heart surgery; fast recovery [14]. Risk: Can occasionally cause a sudden leak in the valve [14].
Valve Repair Considered when a durable repair is anatomically possible [15]. Benefit: Lower risk of infection and bleeding; better long-term survival [15]. Risk: Higher chance of needing another surgery later [16].
Valve Replacement Used when the valve is too scarred or calcified to be repaired [17]. Benefit: Provides a fully functional new valve [18]. Risk: Requires major surgery and long-term medication [19].

Mechanical vs. Bioprosthetic Valves

If you need a replacement, you will choose between two types of valves:

  1. Mechanical Valves: These are made of metal and can last a lifetime [18]. However, they require you to take warfarin every day for the rest of your life to prevent blood clots. This carries a constant risk of bleeding [19].
  2. Bioprosthetic (Tissue) Valves: These are made from animal tissue. They do not usually require lifelong blood thinners, which is often better for women who want to become pregnant [20]. However, these valves wear out faster in younger patients and usually need to be replaced every 10–15 years [18][21].

Finding an Experienced Center

Because RHD is complex, you should seek care at a center that sees many patients with this condition. An experienced center should have [22][23]:

  • A “Heart Team” including cardiologists, surgeons, and specialized nurses.
  • Expertise in PBMV and complex valve repairs, not just replacements.
  • Reliable systems for checking your blood levels (INR) if you are on warfarin.
  • A track record of auditing and maintaining favorable surgical complication rates for complex valve surgery [24][25].

Common questions in this guide

How long do I need penicillin injections for rheumatic heart disease?
Benzathine penicillin G is commonly given every 3 to 4 weeks to help prevent new strep infections and recurrent rheumatic fever. The duration depends on your history, including carditis and the amount of heart damage; treatment may continue for 10 years or until age 21, and severe disease may require injections to age 40 or for life.
What medicines are used when rheumatic heart disease causes heart failure or atrial fibrillation?
Diuretics can reduce fluid buildup, and ACE inhibitors or beta-blockers may be used depending on the valve problem and heart function. For rheumatic heart disease with atrial fibrillation and moderate-to-severe rheumatic mitral stenosis, or with a mechanical valve, warfarin is the standard anticoagulant; do not start or change it without your care team's guidance.
Can a balloon procedure treat severe rheumatic mitral stenosis?
Percutaneous balloon mitral valvuloplasty may be considered when the mitral valve is still flexible and does not have major clots or leakage. It avoids open-heart surgery and may allow faster recovery, but it can sometimes cause a new or worsening valve leak.
When is valve repair used instead of valve replacement for RHD?
Valve repair is considered when the valve's anatomy allows a durable repair and may reduce the risks of infection and bleeding. Replacement is used when the valve is too scarred or calcified to repair, while repair may carry a greater chance of needing another operation later.
What are the differences between mechanical and tissue heart valves?
Mechanical valves can last a lifetime but require lifelong warfarin, which brings an ongoing bleeding risk. Bioprosthetic tissue valves usually do not require lifelong blood thinners and may be considered when pregnancy is planned, but they wear out faster in younger patients and often need replacement after 10 to 15 years.
How should I choose a treatment center for rheumatic heart disease?
Look for a high-volume center with a heart team that includes cardiologists, surgeons, and specialized nurses. The center should have experience with balloon mitral procedures and complex valve repair, reliable INR monitoring for warfarin, and audited outcomes for valve surgery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I a candidate for Percutaneous Balloon Mitral Valvuloplasty (PBMV), or is my valve too damaged/calcified for a balloon procedure?
  2. 2.What is the 10-year success rate for valve repair at your hospital specifically for patients with RHD?
  3. 3.If I need a replacement, would you recommend a mechanical or a bioprosthetic valve for me, and how will that affect my ability to have children or my daily medication routine?
  4. 4.How often will we need to check my INR levels if I am on warfarin, and what support do you offer for monitoring?
  5. 5.Does this surgical center have a dedicated heart-failure team and nurse-led follow-up for RHD patients?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study.

    Kado J, Salman S, Hla TK, et al.

    Antimicrobial agents and chemotherapy 2023; (67(12)):e0096223 doi:10.1128/aac.00962-23.

    PMID: 37971244
  2. 2

    Rheumatic Heart Disease Prophylaxis in Older Patients: A Register-Based Audit of Adherence to Guidelines.

    Holland JV, Hardie K, de Dassel J, Ralph AP

    Open forum infectious diseases 2018; (5(6)):ofy125 doi:10.1093/ofid/ofy125.

    PMID: 29942824
  3. 3

    Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease.

    Bray JJ, Thompson S, Seitler S, et al.

    The Cochrane database of systematic reviews 2024; (9()):CD015779 doi:10.1002/14651858.CD015779.

    PMID: 39312290
  4. 4

    Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.

    Wyber R, Boyd BJ, Colquhoun S, et al.

    Drug delivery and translational research 2016; (6(5)):572-8 doi:10.1007/s13346-016-0313-z.

    PMID: 27465618
  5. 5

    Acute rheumatic fever and rheumatic heart disease among children--American Samoa, 2011-2012.

    Beaudoin A, Edison L, Introcaso CE, et al.

    MMWR. Morbidity and mortality weekly report 2015; (64(20)):555-8.

    PMID: 26020139
  6. 6

    Therapeutics for rheumatic fever and rheumatic heart disease.

    Ralph AP, Currie BJ

    Australian prescriber 2022; (45(4)):104-112 doi:10.18773/austprescr.2022.034.

    PMID: 36110174
  7. 7

    Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial.

    Karthikeyan G, Devasenapathy N, Ghosh A, et al.

    JAMA 2026; (335(23)):2020-2028 doi:10.1001/jama.2026.7335.

    PMID: 42106990
  8. 8

    A Retrospective Study on Drug and Dietary Patterns in Patients With Severe Rheumatic Valvular Heart Disease in Eastern India.

    Das D, Mohanty S, Guru S, et al.

    Cureus 2023; (15(4)):e37358 doi:10.7759/cureus.37358.

    PMID: 37181974
  9. 9

    Anticoagulation for rheumatic mitral stenosis, INVICTUS in perspective.

    Verma R, Latter DA

    Current opinion in cardiology 2023; (38(2)):55-60 doi:10.1097/HCO.0000000000001013.

    PMID: 36718615
  10. 10

    DOACs and rheumatic valvulopathy: always a red light?

    Rochira C, Capodanno D

    European heart journal supplements : journal of the European Society of Cardiology 2023; (25(Suppl B)):B41-B45 doi:10.1093/eurheartjsupp/suad065.

    PMID: 37091632
  11. 11

    Percutaneous mitral balloon commissurotomy in juvenile rheumatic mitral stenosis patients: a ten-year experience from Ethiopia.

    Sebah MB, Mengistu AD, Alene TD, et al.

    BMC cardiovascular disorders 2026; (26(1)).

    PMID: 41877032
  12. 12

    Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty.

    Mohamed Ali A, Packer EJS, Omdal TR, et al.

    Current problems in cardiology 2023; (48(12)):102021 doi:10.1016/j.cpcardiol.2023.102021.

    PMID: 37544629
  13. 13

    Transcatheter heart valve interventions for patients with rheumatic heart disease.

    Weich H, Herbst P, Smit F, Doubell A

    Frontiers in cardiovascular medicine 2023; (10()):1234165 doi:10.3389/fcvm.2023.1234165.

    PMID: 37771665
  14. 14

    Balloon Mitral Valvotomy With the Accura Double-Lumen Balloon Catheter: Immediate and One-Year Clinical Outcomes.

    Khanal S, Yamasandi Siddegowda S, Kumar B

    Cureus 2022; (14(4)):e24610 doi:10.7759/cureus.24610.

    PMID: 35651439
  15. 15

    Meta-Analysis of Mitral Valve Repair Versus Replacement for Rheumatic Mitral Valve Disease.

    Liao YB, Wang TKM, Wang MTM, et al.

    Heart, lung & circulation 2022; (31(5)):705-710 doi:10.1016/j.hlc.2021.11.011.

    PMID: 35120822
  16. 16

    Mitral Valve Surgery in Patients With Rheumatic Heart Disease: Repair vs. Replacement.

    Fu G, Zhou Z, Huang S, et al.

    Frontiers in cardiovascular medicine 2021; (8()):685746 doi:10.3389/fcvm.2021.685746.

    PMID: 34124209
  17. 17

    Rheumatic mitral valve disease: Comparative outcomes of repair versus replacement.

    Araujo S, Silva H, Filho R, et al.

    Global cardiology science & practice 2025; (2025(6)):e202560 doi:10.21542/gcsp.2025.60.

    PMID: 41978891
  18. 18

    Bioprosthetic versus mechanical mitral valve replacements in patients with rheumatic heart disease.

    Chen CY, Chan YH, Wu VC, et al.

    The Journal of thoracic and cardiovascular surgery 2023; (165(3)):1050-1060.e8 doi:10.1016/j.jtcvs.2021.03.033.

    PMID: 33840468
  19. 19

    Medium-term outcomes from mitral valve surgery for rheumatic heart disease in young adults in Aotearoa New Zealand: a cohort study.

    Singh N, Haydock DA, Goh SSC

    ANZ journal of surgery 2022; (92(5)):1060-1065 doi:10.1111/ans.17685.

    PMID: 35403789
  20. 20

    Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease.

    van Hagen IM, Thorne SA, Taha N, et al.

    Circulation 2018; (137(8)):806-816 doi:10.1161/CIRCULATIONAHA.117.032561.

    PMID: 29459466
  21. 21

    Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50-70 Years.

    Yu J, Wang W

    Frontiers in cardiovascular medicine 2022; (9()):904958 doi:10.3389/fcvm.2022.904958.

    PMID: 35711344
  22. 22

    A Human-Centered Approach to CV Care: Infrastructure Development in Uganda.

    Longenecker CT, Kalra A, Okello E, et al.

    Global heart 2018; (13(4)):347-354 doi:10.1016/j.gheart.2018.02.002.

    PMID: 29685638
  23. 23

    Outcomes for patients with rheumatic heart disease after cardiac surgery followed at rural district hospitals in Rwanda.

    Rusingiza EK, El-Khatib Z, Hedt-Gauthier B, et al.

    Heart (British Cardiac Society) 2018; (104(20)):1707-1713 doi:10.1136/heartjnl-2017-312644.

    PMID: 29678896
  24. 24

    Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in sub-Saharan Africa.

    Tamirat S, Mazine A, Stevens LM, et al.

    The Journal of thoracic and cardiovascular surgery 2021; (162(6)):1714-1725.e2 doi:10.1016/j.jtcvs.2020.02.139.

    PMID: 33168165
  25. 25

    A 17-Year Experience of Valvular Heart Surgery in Rwanda.

    Musoni M, Wang S, Schulick N, et al.

    The Annals of thoracic surgery 2026; (121(2)):393-400 doi:10.1016/j.athoracsur.2025.06.008.

    PMID: 40550320

This page is for informational purposes only and does not constitute medical advice. Your cardiologist and heart team can tailor antibiotic prophylaxis, medicines, anticoagulation, and valve treatment to your situation.

Get notified when new evidence is published on rheumatic heart disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.